Microsatellite instability: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 29: Line 29:
{{Genetics-stub}}
{{Genetics-stub}}
{{Cancer-stub}}
{{Cancer-stub}}
<gallery>
File:Tumour-infiltrating_lymphocytes_-_2_--_extremely_high_mag.jpg|Tumour-infiltrating lymphocytes at extremely high magnification
File:Microsatellite_Instability_in_GeneMarker.jpg|Microsatellite Instability in GeneMarker
File:MSI_detection_by_real_time_PCR.jpg|MSI detection by real-time PCR
</gallery>

Latest revision as of 04:20, 18 February 2025

Microsatellite instability (MSI) is a condition that appears in the DNA of specific cells (such as cancer cells) where the number of microsatellite repeats in these cells is different than the repeats in normal DNA. Microsatellites, also known as short tandem repeats (STRs), are repeating sequences of 1-6 base pairs of DNA. MSI is a form of genomic instability and is found in many types of human cancer.

Causes[edit]

MSI is caused by defects in the mismatch repair (MMR) system of the cell. The MMR system corrects errors that spontaneously occur during DNA replication, such as single base mismatches or short insertions and deletions. The proteins involved in MMR correct these errors by forming a complex that binds to the mismatched DNA, excises the error, and uses the original DNA strand as a template to correct the mismatch.

Role in Cancer[edit]

MSI is a common feature of certain types of cancer. It is most often associated with colorectal cancer, endometrial cancer, and gastric cancer. In these cancers, the MMR system is defective, leading to an accumulation of errors in the DNA and resulting in genomic instability. This instability can lead to the development of cancer.

Diagnosis[edit]

Diagnosis of MSI involves testing the DNA of tumor cells for the presence of microsatellite instability. This is typically done using polymerase chain reaction (PCR) to amplify microsatellite regions, followed by analysis of these regions to detect any changes in the number of repeats.

Treatment and Prognosis[edit]

The presence of MSI in a tumor can have implications for treatment and prognosis. Tumors with high levels of MSI (known as MSI-H) are often more responsive to immunotherapy than tumors without MSI. Additionally, patients with MSI-H tumors often have a better prognosis than those with microsatellite stable (MSS) tumors.

See Also[edit]

This article is a stub related to genetics. You can help WikiMD by expanding it!


Stub icon
   This article is a oncology stub. You can help WikiMD by expanding it!